CD19 and neoplasm: Imaging performed on D21 PI revealed a significant decrease in the total flux from all mice that received CD19 CAR-expressing T cells compared with Group NC (Figure 4B), suggesting that CD19 CAR-expressing T cells effectively killed Daudi-Fluc tumor cells.